Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

LumiMeds review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

LumiMeds carries a 2025 FDA warning letter over how it described its compounded medication. Semaglutide: $89/mo advertised flat rate; tirzepatide: $125/mo advertised flat rate. The promotion promises a price lock, but terms reserve price changes, restrict mid-term cancellation and apply a $100 deduction to applicable refunds.

$89/mo
Consult Medication Shipping Coaching
See plans at LumiMeds
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

LumiMeds at a glance

Semaglutide
$89/mo advertised flat rate
Tirzepatide
$125/mo advertised flat rate
Coverage
All 50 states
Brand-name
Compounded only

How we scored LumiMeds

Every factor comes from LumiMeds's own published pricing, disclosures and oversight, and the six combine into the 49/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance30/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit35/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs62/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost58/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support58/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness60/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

LumiMeds carries a 2025 FDA warning letter over how it described its compounded medication. Semaglutide: $89/mo advertised flat rate; tirzepatide: $125/mo advertised flat rate. The promotion promises a price lock, but terms reserve price changes, restrict mid-term cancellation and apply a $100 deduction to applicable refunds.

Before you sign up

What LumiMeds's public site and signup page show before you hand over any details.

Worth knowing

  • Homepage lists 'From $X/month' starting prices for semaglutide, tirzepatide, and NAD+ directly, before any intake
  • A BMI/weight-loss projection tool runs on the homepage using self-reported patient outcome data, not a clinical guarantee
  • A named Medical Director (Dr. Teresa Walsh, M.D.) is credited, stated as 'Licensed in all 50 states'
  • States 'No membership required' on every plan tile
  • A named, credentialed Medical Director with explicit all-50-state licensure is a stronger trust signal than most long-tail providers
  • 'From $X/month' framing means the exact price at a working dose isn't guaranteed by the homepage number alone
  • HSA/FSA accepted, and Klarna financing is offered on select plans
  • No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS

Pricing

MedicationPricePlan
Compounded semaglutide$89Advertised flat planPromotion advertises price locked; monthly and multi-month plans available. Medication, review, shipping included; terms assess $100 cancellation deduction from applicable refunds unless prescription denied.
Compounded tirzepatide$125Advertised flat planSame price at each dose, no membership; promotion advertises price lock. Cancellation refund deduction applies.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what LumiMeds's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Named Medical Director (Dr. Teresa Walsh, M.D.) stated as licensed in all 50 states
  • No membership required on any plan
  • HSA/FSA accepted, plus Klarna financing on select plans
  • Also offers NAD+ injectable therapy on the same platform
  • Semaglutide: $89/mo advertised flat rate; tirzepatide: $125/mo advertised flat rate.

The caveats

  • No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
  • FDA warning letter (#716510, issued September 9, 2025) cites Lumimeds for describing its compounded semaglutide/tirzepatide as equivalent to FDA-approved brand medication — compounded drugs are not FDA-approved, and the letter found the comparison misleading
  • No named compounding pharmacy found on the pages checked
  • No brand-name (FDA-approved) option and no oral form
  • The promotion promises a price lock, but terms reserve price changes, restrict mid-term cancellation and apply a $100 deduction to applicable refunds.

LumiMeds' FDA warning belongs in the decision

LumiMeds received FDA warning letter #716510, issued September 9, 2025, over false or misleading descriptions of its compounded semaglutide and tirzepatide, including comparisons with approved brand medication. A warning letter is a regulatory communication, not a finding about every individual prescription or a guarantee that a company has closed. It is relevant to how you evaluate the seller's product claims. Compounded preparations are not FDA-approved finished medicines, and the shared active ingredient should not be treated as proof that the preparation is equivalent to a branded product. Read the regulatory disclosure alongside the current offer.

The current advertised flat rates are $89 per month for semaglutide and $125 for tirzepatide. Provider review, medication and delivery are described as included, with no membership fee and no dose-related price increase. Monthly and longer plans are available. Those features make the initial package understandable, but the promotion's promise that the price stays locked needs to be read with the contract. Confirm the actual term and total before paying, rather than assuming every plan can be purchased one month at a time for the headline amount or canceled with the same refund treatment.

The contract qualifies the price-lock and cancellation promises

LumiMeds' terms reserve the right to change membership pricing with twenty-eight days' notice, while the public promotion promises a continuing price lock. The terms also describe commitment periods as noncancelable and non-refundable, with outstanding payments remaining due. Elsewhere, a $100 cancellation deduction is described for applicable refunds unless a provider denies the prescription. Those provisions should not be simplified into a universal cancel-anytime refund promise. Ask which contract applies to your selected plan, how the promotional rate is protected and what obligation remains if you stop treatment before a longer term ends.

The fee does not mean a refund is always available after subtracting $100; it is a deduction from a refund that is otherwise applicable. Prescription denial is treated differently from changing your mind or stopping after approval. Before committing, establish when a charge is captured, when the pharmacy begins preparation and what cancellation can still prevent at each stage. Financing also deserves its own explanation. A payment plan can make an upfront purchase easier to fund without giving you a right to end the remaining installments merely because you no longer want future shipments.

A named medical director does not identify your dispenser

The company identifies Dr. Teresa Walsh, MD, as medical director and advertises nationwide clinical access. It does not clearly name the compounding pharmacy in its main public program information. Ask who will prescribe in your state, which pharmacy would fill the preparation and how to contact the care team between orders. Its homepage weight-loss projections use self-reported patient information rather than a personal guarantee. Neither a projection nor the medical director's title establishes the result you should expect. The useful questions concern the specific formulation, clinical review and follow-up attached to your own prescription.

LumiMeds accepts HSA/FSA payment and offers financing on selected plans, but it does not describe a dedicated maternal or PCOS pathway. Raise pregnancy planning, nursing history and other hormonal concerns before the prescriber recommends a treatment or commitment length. The service may interest someone looking for a flat advertised compounded price, provided the pharmacy and contract questions receive clear answers. Its lower sticker should not overshadow the FDA letter or the tension between marketing and written terms. Evaluate the complete treatment and financial obligations together, especially when family plans or changing health circumstances could make an early stop necessary.

The bottom line for mothers

Best for: Someone comfortable with the stated plan commitment who confirms the full prescribed treatment cost before paying.

Alternatives to LumiMeds

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Compounded semaglutide at $99 a month and tirzepatide at $149, month to month and the same price at every dose, plus a separate microdose line for anyone who wants a gentler metabolic effect rather than maximum weight loss. Lttl covers all 50 states and Washington D.C., says it prescribes and ships within 48 hours, and attributes compounding to U.S.A.-licensed pharmacies it does not name. The catalog runs well past weight loss into NAD+, sermorelin, glutathione and B12 from $79, so read the longevity menu as a separate business from the GLP-1 you came for. Prepaying for a year brings it to $89 and $139 a month, and the first-order discount of up to $140 is promotional.

    Visit Lttl
  • Compounded semaglutide at $99 a month and tirzepatide at $149, month to month, one price at every dose that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. The $69 and $119 on its homepage are the 12-month prepay rates, billed once up front with no refund for unused months, and they sit under a live countdown clock with a lock-for-life promise that is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.

    Visit SnagRx

Providers like LumiMeds

Keep comparing LumiMeds

LumiMeds, answered

How much does LumiMeds cost?
At last review, LumiMeds's lowest ongoing compounded rate was about $89/mo — $89/mo advertised flat rate for semaglutide, $125/mo advertised flat rate for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
Is LumiMeds safe to use while breastfeeding?
No GLP-1 is established as safe in pregnancy. Nursing is less clear-cut. The Wegovy injection, Ozempic, Zepbound and Mounjaro labels have little or no breast-milk data and ask you and your clinician to weigh the benefits of breastfeeding against how much you need the drug. Compounded versions carry no label of their own, which puts more of that judgment on your prescriber. LumiMeds is not an exception to any of that — settle the timing with your own clinician.
Does LumiMeds offer both semaglutide and tirzepatide?
Yes — LumiMeds offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
How does LumiMeds score for mothers?
LumiMeds scores 49/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.

Pricing, states and verification reflect LumiMeds's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers